Alere executives filed a complaint in Delaware Chancery Court Aug. 26 alleging Abbott failed to obtain the necessary U.S. antitrust approvals for the merger.
In March, Alere disclosed the Justice Department had subpoenaed documents from the company to investigate Alere’s overseas business practices.
Alere has since disclosed a separate U.S. investigation into billing practices at a Texas-based laboratory., according to the article.
Despite Alere’s legal troubles, Abbott said in a statement that the company remains committed to the acquisition.
More articles on legal and regulatory issues:
Michigan health department appeals secret court order
Illinois OKs EMTs to use syringe over EpiPen
SC Supreme court declines to rule on Greenville Health System’s switch to partially private hospital
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.